Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients

Kidney International

Volumn 68, Issue 6, 2005, Pages 2857-2862

  Winkelmayer, Wolfgang C ^a   Kramar, Reinhard ^b   Sunder Plassmann, Gere ^b   Födinger, Manuela ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Allograft loss; Chronic allograft nephropathy; Homocysteine; Kidney transplantation; Mortality; MTHFR; MTRR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE REDUCTASE;

ADULT; ARTICLE; FEMALE; GENOTYPE; GRAFT FAILURE; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; FEMALE; FERREDOXIN-NADP REDUCTASE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 32844475667     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00759.x     Document Type: Article

References (30)

1. BOSTOM AG, SILBERSHATZ H, ROSENBERG IH, et al: Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077-1080, 1999
2. BOSTOM AG, ROSENBERG IH, SILBERSHATZ H, et al: Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann Intern Med 131:352-355, 1999
3. KARK JD, SELHUB J, BOSTOM A, et al: Plasma homocysteine and all-cause mortality in diabetes [letter]. Lancet 353:1936-1937, 1999
4. VASAN RS, BEISER A, D'AGOSTINO RB, et al: Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. J Am Med Assoc 289:1251-1257, 2003
5. BOSTOM AG, SHEMIN D, VERHOEF P, et al: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 17:2554-2558, 1997
6. DUCLOUX D, MOTTE G, CHALLIER B, et al: Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: A prospective study. J Am Soc Nephrol 11:134-137, 2000
7. WINKELMAYER WC, KRAMAR R, CURHAN GC, et al: Fasting plasma total-homocysteine levels and mortality and allograft loss in kidney transplant recipients. A prospective study. J Am Soc Nephrol 16:255-260, 2005
8. JACQUES PF, BOSTOM AG, WILLIAMS RR, et al: Relation between folate status, a common mutation in methylenetetrahydrofolate-reductase, and plasma homocysteine concentration. Circulation 93:7-9, 1996
9. FÖDINGER M, WÖLfl G, FISCHER G, et al: Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int 55:1072-1080, 1999
10. FÖDINGER M, MANNHALTER C, WÖLFL G, et al: Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52:517-523, 1997
11. WRONE EM, ZEHNDER JL, HORNBERGER JM, et al: An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int 60:1106-1113, 2001
12. LIANGOS O, KREUTZ R, BEIGE J, et al: Methylentetrahydrofolate-reductase gene C677T variant and kidney-transplant survival. Nephrol Dial Transplant 13:2351-2354, 1998
13. HAGEN W, FÖDINGER M, HEINZ G, et al: Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients. Kidney Int 59(Suppl 78):S253-S257, 2001
14. COCKCROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
15. 12 plasma concentrations in kidney graft recipients. J Am Soc Nephrol 11:1918-1925, 2000
16. FROSST P, BLOM HJ, MILOS R, et al: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113, 1995
17. WEISBERG I, TRAN P, CHRISTENSEN B, et al: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172, 1998
18. RADY PL, SZUCS S, GRADY J, et al: Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas: A report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107:162-168, 2002
19. 12) increases risk for spina bifida. Mol Genet Metab 67:317-323, 1999
20. 12 concentrations in renal transplant patients. Atherosclerosis 174:43-48, 2004
21. KOCSIS I, GYÖRFFY B, NÉMETH E, VÁSÁRHELYI B: Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool. Kidney Int 65:1956-1958, 2004
22. MEIER-KRIESCHE HU, ARNDORFER JA, KAPLAN B: The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73:70-74, 2002
23. WINKELMAYER WC, LORENZ M, KRAMAR R, et al: C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant 4:1148-1154, 2004
24. DUCLOUX D, KAZORY A, CHALOPIN JM: Predicting coronary heart disease in renal transplant recipients: A prospective study. Kidney Int 66:441-447, 2004
25. WINKELMAYER WC, EBERLE C, FÖDINGER M, SUNDER-PLASSMANN G: Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63:2280-2285, 2003
26. AUCELLA F, MARGAGLIONE M, GRANDONE E, et al: The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: Results of a multicentre prospective study. Nephrol Dial Transplant 20:382-386, 2005
27. HEIDENREICH S, JUNKER R, WOLTERS H, et al: Outcome of kidney transplantation in patients with inherited thrombophilia: Data of a prospective study. J Am Soc Nephrol 14:234-239, 2003
28. CHRISTEN WG, AJANI UA, GLYNN RJ, et al: Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Intern Med 160:422-434, 2000
29. 12 in kidney transplant recipients. Kidney Int 67:1980-1985, 2005
30. YOLA M, LUCIEN A: Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol 47:731-737, 1994